Company : FIBREGA

Home / Company

Do humans have the capacity to regenerate?

We have witnessed the powerful effects of FIBREGA and PRG Pharma Pvt Ltd, officially announced the development of the world's first commercial Fibronectin (FIBREGA) which will benefit the construction of cell regeneration and repair. The basic components of FIBREGA regulate a dynamic balance between the cell and its extracellular matrix by constructing a microenvironment for the cell to regenerate.The main objective of FIBREGA is to regenerate and heal, which contributes to the patient's treatment for the fastest recovery.

Getting into FIBREGA

Fibronectin is a high-molecular-weight (~440kDa) glycoprotein of the extracellular matrix that binds to membrane-spanning receptor proteins called integrins. Fibronectin also binds to other extracellular matrix proteins such as collagen, fibrin, and heparan sulfate proteoglycans (e.g. syndecans).” (referred by Wikipedia) With the help of our scientific research and development, PRG Pharma Pvt Ltd has successfully developed a formula that helps a lot of patients to recover their lost life and skin. Without FIBREGA, wound regeneration and healing would not be possible.